- Home
- CMMB vs ELSE Comparison
CMMB vs ELSE Comparison
Compare CMMB & ELSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMMB
- ELSE
- Stock Information
- Founded
- CMMB 2004
- ELSE 1968
- Country
- CMMB Israel
- ELSE United States
- Employees
- CMMB N/A
- ELSE N/A
- Industry
- CMMB Biotechnology: Pharmaceutical Preparations
- ELSE Industrial Machinery/Components
- Sector
- CMMB Health Care
- ELSE Industrials
- Exchange
- CMMB Nasdaq
- ELSE Nasdaq
- Market Cap
- CMMB 15.8M
- ELSE 13.2M
- IPO Year
- CMMB N/A
- ELSE N/A
- Fundamental
- Price
- CMMB $1.51
- ELSE $3.90
- Analyst Decision
- CMMB Strong Buy
- ELSE
- Analyst Count
- CMMB 3
- ELSE 0
- Target Price
- CMMB $5.67
- ELSE N/A
- AVG Volume (30 Days)
- CMMB 206.1K
- ELSE 2.2K
- Earning Date
- CMMB 11-07-2024
- ELSE 11-12-2024
- Dividend Yield
- CMMB N/A
- ELSE N/A
- EPS Growth
- CMMB N/A
- ELSE N/A
- EPS
- CMMB N/A
- ELSE 0.06
- Revenue
- CMMB N/A
- ELSE $8,834,000.00
- Revenue This Year
- CMMB N/A
- ELSE N/A
- Revenue Next Year
- CMMB N/A
- ELSE N/A
- P/E Ratio
- CMMB N/A
- ELSE $63.66
- Revenue Growth
- CMMB N/A
- ELSE 3.78
- 52 Week Low
- CMMB $0.42
- ELSE $3.65
- 52 Week High
- CMMB $2.55
- ELSE $4.40
- Technical
- Relative Strength Index (RSI)
- CMMB 43.28
- ELSE 46.18
- Support Level
- CMMB $1.29
- ELSE $3.91
- Resistance Level
- CMMB $1.58
- ELSE $4.05
- Average True Range (ATR)
- CMMB 0.15
- ELSE 0.03
- MACD
- CMMB -0.04
- ELSE -0.01
- Stochastic Oscillator
- CMMB 39.29
- ELSE 0.00
About CMMB Chemomab Therapeutics Ltd.
Chemomab Therapeutics Ltd is a clinical-stage biotech company, focusing on the discovery and development of therapeutics for fibrosis-related diseases with large unmet needs. The company's candidate, CM-101, is a monoclonal antibody that targets CCL24 and was shown to interfere with the underlying biology of liver, skin and lung fibrosis using a novel and differentiated mechanism of action. CM-101 has demonstrated the potential to treat multiple severe and life threatening fibrotic and inflammatory diseases. It is advancing three Phase 2 clinical trials in parallel for CM-101 treating rare fibrotic conditions.
About ELSE Electro-Sensors Inc.
Electro-Sensors Inc is engaged in manufacturing and selling a variety of monitoring systems that measure actual machine production and operation rates, as well as systems that regulate the speed of related machines in production processes. Its speed monitoring systems compare revolutions per minute or speed against acceptable rates as determined by a customer. It also includes a line of products that measure production counts or rates, such as parts, gallons, or board feet, alarm systems, tachometers, and other devices that translate impulses from the sensors into alarm signals, computer inputs, or digital displays that are usable by the customer.